Abstract:AT1R expression is increased in the nucleus of solitary tract (NTS) of many animal models of hypertension. However, the impact of its chronic regulation on cardiovascular control is not well understood. In this study, we investigated the hypothesis that NTS AT1R is involved in peripheral inflammatory status and hypertension-linked cardiovascular pathophysiology. AAV2- mediated expression of a shRNA targeted the AT1R in the NTS has been used to test the hypothesis. First,the efficacy of the AAV2-AR1R-shRNA was established with the use of neuronal cells in primary culture. Transduction of these cultures by AAV2-AT1R-shRNA resulted in a 72% decrease in AT1R mRNA compared with the AAV2- Sc-shRNA transduced control. This was accompanied by complete attenuation of AngII-induced increase in ERK1/2 phosphorylation and neuronal action potential frequency (control: 2.2±0.4 vs. AT1R-shRNA: 0.5±0.3 hz). We then microinjected AAV2-AT1R-shRNA or control vector, AAV2-Scrambled (Sc)-shRNA into the NTS of 8-week-old SHR and WKY rats. Nine weeks following microinjection, AAV2-AT1R-shRNA group of SHRs showed a 29 mmHg increase in mean arterial pressure (MAP) (control: 154.2±4.7; shRNA: 183.0±10.2 mmHg), insignificant effects on the MAP of WKY rats was observed. The increase in MAP in the SHR by AAV2-AT1R-shRNA was associated with a 42% decrease in baroreflex bradycardia (control: 0.57±0.02; shRNA: 0.33±0.06 ms/mmHg), profound cardiac hypertrophy, and significant increase in the plasma norepinephrine (control: 6.36±0.39, shRNA: 13.0±4.13 ng/mL). In addition, AAV2-AT1R-shRNA rats showed significant increases in water intake (control: 32.5±1.5; shRNA: 12.5±2.5 ml/16h) and urine output (control: 1.6 ±0.5; shRNA: 9.3±2.5 ml/16h). Furthermore, AAV2-AT1R-shRNA treated SHR exhibited 74% decrease in circulating endothelial progenitor cells (EPC, CD90+, CD4/5/8-), and ∼300% increases in inflammatory cells (IC) including CD4/8+, T lymphocytes (CD45/3+) and macrophages (CD68+) . As a result, EPC/IC ratio was decreased by 8∼15 fold in AT1R-shRNA treated SHR. These observations suggest that increased AT1R in the NTS of SHR may present a counter-hypertensive mechanism involving inflammatory/angiogenic cells.

Dysfunction of myocardial and vascular taurine transport in L-N ω-nitro-arginine-induced hypertensive rats

Dysfunction of Myocardial and Vascular Taurine Transport in Spontaneously Hypertensive Rats.

Effects of Taurine on Gut Microbiota and Metabolism in Mice

Dysfunction of Myocardial Taurine Transport and Effect of Taurine Supplement in Rats with Isoproterenol-Induced Myocardial Injury.

[An Observation of Taurine Transport Alterations in Calcification of Myocardial Cells in Vitro].

Alteration of mevalonate pathway related enzyme expressions in pressure overload-induced cardiac hypertrophy and associated heart failure with preserved ejection fraction.

Low-dose Taurine Upregulates Taurine Transporter Expression in Acute Myocardial Ischemia.

Abstract 394: Chronic Knockdown of the NTS AT1R Increases Circulating Inflammatory-Endothelial Progenitor Cells Ratio and Exacerbates Hypertension in the SHR

Effect of taurine on L-arginine/NO pathway in erythrocytes of rats of hypertension with insulin resistance induced by fructose

Taurine Supplementation Alleviates Blood Pressure via Gut–Brain Communication in Spontaneously Hypertensive Rats

Gut Microbiota Dependent Trimethylamine N-oxide Aggravates Angiotensin II-induced Hypertension.

Protective effects of taurine on LPS-induced myocardial damage in rats

Taurine attenuates the vascular calcification and L-arginine/NO pathway impairement induced by vitamin D3 and nicotine in rat

[L-Arginine Transport in Cultured Vascular Smooth Muscle Cells of Spontaneously Hypertensive Rats and Effect of Liposome on the Transport].

HYPERGLYCEMIA INHIBITED TAURINE TRANSPORT AND TAURINE TRANSPORTER GENE EXPRESSION IN CULTURED RAT CARDIOMYOCYTES

Changes in Adrenomedullin and Receptor Activity-Modifying Protein 2 Mrna in Myocardium and Vessels During L-NNA-induced Hypertension in Rats

The Renal L-arginine/nitric Oxide Pathway and Erythrocyte L-arginine Transport in Spontaneously Hypertensive Rats

Prevention of myocardial fibrosis by using nitrendipine to the spontaneously hypertensive rats

Endogenous Taurine Downregulation is Required for Renal Injury in Salt-Sensitive Hypertensive Rats Via CBS/H2S Inhibition

Taurocholic acid ameliorates hypertension through activation of TGR5 in hypothalamic paraventricular nucleus

Taurine Attenuates Oxidative Stress and Alleviates Cardiac Failure in Type I Diabetic Rats